Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19N3O |
| Molecular Weight | 281.3523 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N1CCCCC1)C2=CC=CC=C2NC3=CC=NC=C3
InChI
InChIKey=YMODINPJYNHPTM-UHFFFAOYSA-N
InChI=1S/C17H19N3O/c21-17(20-12-4-1-5-13-20)15-6-2-3-7-16(15)19-14-8-10-18-11-9-14/h2-3,6-11H,1,4-5,12-13H2,(H,18,19)
| Molecular Formula | C17H19N3O |
| Molecular Weight | 281.3523 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://doi.org/10.1002/ddr.430200303
Sources: https://doi.org/10.1002/ddr.430200303
Ofornine is a vasodilator with antihypertensive activity. Experiments on rats have shown that ofornine reduced spontaneously hypertensive (SH) blood pressure through vasodilating and presynaptic adrenolytic activities, and that a dopaminergic mechanism may be involved. Information about the current use of this drug is not available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:46:28 GMT 2025
by
admin
on
Wed Apr 02 08:46:28 GMT 2025
|
| Record UNII |
WK1LBP1F3L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C270
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
55754
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
100000083291
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
5605
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
SUB09423MIG
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
C81526
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105194
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
W-23
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
WK1LBP1F3L
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
289-346-3
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
DTXSID60236626
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY | |||
|
87784-12-1
Created by
admin on Wed Apr 02 08:46:28 GMT 2025 , Edited by admin on Wed Apr 02 08:46:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |